Crushed by nearly 77% in one year, Adocia stock rebounds by more than 7%

A sharp rebound that leaves the stock 50% below its 200-day moving average

The Adocia stock gains 7.19% to €2.33, placing it among the strongest gainers on the CAC All Shares. Over the week, it advances 12.58%, but still loses 39.68% over three months and nearly 77% over one year. The rebound therefore erases only a small portion of the quarterly decline: it mitigates it without reversing it.

The price remains below its MA50 (gap of -32.77%) as well as its MA200 (gap of -50.93%). The RSI at 25.78 reflects an oversold configuration following this slide, while the support level of €2.01 remains at approximately 14% below the current price.

Cash position until the second quarter of 2027 and uncertainty over business continuity

On the fundamentals side, Adocia published its half-year results on September 25: the loss is reduced to €8.6 million and cash is considered sufficient until the beginning of the second quarter of 2027. However, the report notes significant uncertainty regarding business continuity, with the company having concentrated its resources on its BioChaperone platform. The group also announced its participation in two international conferences, including EASD 2026, where data on AdoShell and the results of the phase 3 study conducted in China will be presented. Going forward, the €2.01 level serves as a reference point: it is the level the stock had approached before this rebound.